22 January 2025

Exploring the Pros and Cons of GLP-1 Agonists: Weight Loss, Cognitive Benefits, and Health Risks

The use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as Ozempic, Wegovy, Mounjaro, and Zepbound, for weight loss has been on the rise. Originally developed to manage type 2 diabetes, these medications have become popular for their potential to support weight loss.

Recent studies highlight both positive and negative side effects of GLP-1 medications. While they are associated with benefits like improved cognitive and behavioral health, including a reduced risk of addiction, they also carry risks such as pancreatitis, gastrointestinal problems, kidney issues, gastroparesis, and bowel obstruction.

For instance, research published in October 2023 revealed a connection between GLP-1 drugs and an increased likelihood of pancreatitis and digestive tract conditions. Conversely, other studies suggest these medications may reduce risks of cardiovascular disease and dementia, offering significant potential for broader health benefits.